Vijay Kumar

Stock Analyst at Evercore ISI

(4.52)
# 1,079
Out of 5,144 analysts
556
Total ratings
56%
Success rate
7.9%
Average return

Stocks Rated by Vijay Kumar

Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $100 → $112
Current: $105.43
Upside: +6.23%
Revvity
Nov 3, 2026
Reiterated: Buy
Price Target: $126 → $180
Current: $147.79
Upside: +21.79%
Illumina
Oct 30, 2026
Reiterated: Buy
Price Target: $200 → $275
Current: $202.61
Upside: +35.73%
NovoCure
Oct 30, 2026
Reiterated: Buy
Price Target: $20
Current: $11.14
Upside: +79.53%
Stryker
Oct 30, 2026
Reiterated: Buy
Price Target: $350 → $320
Current: $317.54
Upside: +0.77%
Avantor
Oct 28, 2026
Reiterated: Hold
Price Target: $14 → $17
Current: $15.18
Upside: +11.99%
Abbott Laboratories
Oct 23, 2026
Reiterated: Buy
Price Target: $112 → $120
Current: $104.71
Upside: +14.60%
Agilent Technologies
Aug 27, 2026
Reiterated: Buy
Price Target: $148 → $172
Current: $172.22
Upside: -0.13%
Enovis
Aug 7, 2026
Reiterated: Buy
Price Target: $32
Current: $27.22
Upside: +17.56%
iRhythm Holdings
Aug 7, 2026
Reiterated: Buy
Price Target: $150 → $165
Current: $89.67
Upside: +84.02%
Reiterated: Buy
Price Target: $35
Current: $45.81
Upside: -23.60%
Reiterated: Buy
Price Target: $25 → $26
Current: $19.94
Upside: +30.39%
Reiterated: Buy
Price Target: $30 → $23
Current: $23.78
Upside: -3.28%
Reiterated: Buy
Price Target: $410 → $420
Current: $449.78
Upside: -6.62%
Reiterated: Hold
Price Target: $17
Current: $20.83
Upside: -18.39%
Reiterated: Buy
Price Target: $65 → $55
Current: $43.03
Upside: +27.82%
Reiterated: Buy
Price Target: $80 → $84
Current: $81.84
Upside: +2.64%
Reiterated: Buy
Price Target: $22 → $24
Current: $25.76
Upside: -6.83%
Reiterated: Buy
Price Target: $180
Current: $215.42
Upside: -16.44%
Reiterated: Buy
Price Target: $225 → $230
Current: $225.77
Upside: +1.87%
Reiterated: Buy
Price Target: $160 → $200
Current: $143.28
Upside: +39.59%
Reiterated: Hold
Price Target: $480 → $430
Current: $430.53
Upside: -0.12%
Reiterated: Buy
Price Target: $106 → $105
Current: $102.32
Upside: +2.62%
Reiterated: Buy
Price Target: $1,425 → $1,350
Current: $1,712.95
Upside: -21.19%
Reiterated: Buy
Price Target: $335 → $320
Current: $319.11
Upside: +0.28%
Reiterated: Buy
Price Target: $575 → $570
Current: $686.79
Upside: -17.01%
Downgraded: Hold
Price Target: $56 → $102
Current: $112.00
Upside: -8.93%
Reiterated: Buy
Price Target: $120 → $110
Current: $102.09
Upside: +7.75%
Reiterated: Buy
Price Target: $350 → $320
Current: $414.12
Upside: -22.73%
Reiterated: Hold
Price Target: $3
Current: $3.51
Upside: n/a
Reiterated: Buy
Price Target: $160 → $150
Current: $134.60
Upside: n/a
Reiterated: Buy
Price Target: $2 → $2.5
Current: $0.5616
Upside: n/a
Reiterated: Buy
Price Target: $93
Current: $268.07
Upside: n/a